|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001128,
umls-concept:C0008976,
umls-concept:C0023413,
umls-concept:C0024623,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0123931,
umls-concept:C0205179,
umls-concept:C0246415,
umls-concept:C0282460,
umls-concept:C1705294
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-9-7
|
|
pubmed:abstractText |
The optimal chemotherapy in patients with advanced gastric carcinoma (GC) is yet to be determined. We compared sequential administration of docetaxel and irinotecan, both in combination with infused 5-fluorouracil/leucovorin (5-Fu/Lv), and randomly assigned patients to start with either of the two.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1436-3291
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
155-61
|
|
pubmed:meshHeading |
pubmed-meshheading:20820984-Adenocarcinoma,
pubmed-meshheading:20820984-Adult,
pubmed-meshheading:20820984-Aged,
pubmed-meshheading:20820984-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20820984-Camptothecin,
pubmed-meshheading:20820984-Disease-Free Survival,
pubmed-meshheading:20820984-Female,
pubmed-meshheading:20820984-Fluorouracil,
pubmed-meshheading:20820984-Humans,
pubmed-meshheading:20820984-Leucovorin,
pubmed-meshheading:20820984-Male,
pubmed-meshheading:20820984-Middle Aged,
pubmed-meshheading:20820984-Questionnaires,
pubmed-meshheading:20820984-Statistics as Topic,
pubmed-meshheading:20820984-Stomach Neoplasms,
pubmed-meshheading:20820984-Survival Analysis,
pubmed-meshheading:20820984-Taxoids,
pubmed-meshheading:20820984-Time Factors,
pubmed-meshheading:20820984-Vitamin B Complex
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial.
|
|
pubmed:affiliation |
Department of Oncology, Karolinska University Hospital at Södersjukhus, Sjukhusbacken 10, SE-118 83, Stockholm, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
